Skip to main content

Advertisement

Open Peer Review Reports for: Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
20 Mar 2009 Submitted Original manuscript
23 Apr 2009 Reviewed Reviewer Report - Raymund Roos
21 May 2009 Reviewed Reviewer Report - Ralf Reilmann
14 Jul 2009 Author responded Author comments - Samuel Frank
Resubmission - Version 2
14 Jul 2009 Submitted Manuscript version 2
11 Sep 2009 Reviewed Reviewer Report - Raymund Roos
17 Nov 2009 Author responded Author comments - Samuel Frank
Resubmission - Version 3
17 Nov 2009 Submitted Manuscript version 3
1 Dec 2009 Author responded Author comments - Samuel Frank
Resubmission - Version 4
1 Dec 2009 Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
10 Dec 2009 Author responded Author comments - Samuel Frank
Resubmission - Version 6
10 Dec 2009 Submitted Manuscript version 6
Publishing
18 Dec 2009 Editorially accepted
18 Dec 2009 Article published 10.1186/1471-2377-9-62

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement